Now, as part of Arcutis Biotherapeutics ' Free to Be Me awareness campaign, Spelling is opening up about the emotional toll ...
Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback